Document Type

Book Chapter

Publisher

Taylor & Francis, forthcoming

Publication Date

2024

Abstract

Soon after the Supreme Court issued Dobbs v. Jackson Women’s Health Organization—a case that overturned the right to abortion—roughly a third of the country enacted a total or near-total abortion ban. Women’s healthcare has suffered in a variety of ways as a result. This chapter considers an underappreciated harm of abortion bans: their impact on rheumatology practice. It considers three chilling effects that have resulted from state abortion bans: (1) a hesitation to prescribe rheumatology medications that can cause abortion, like methotrexate; (2) a hesitation to prescribe rheumatology medications with teratogenicity (i.e., those that can cause fetal anomaly), and (3) a hesitation to refer patients to abortion providers out of state. Though liability for these actions is unlikely, the high penalties of abortion bans coupled with aggressive, antiabortion prosecutors, have created a culture of fear that has intruded into the practice of medicine, harming patients far beyond reproductive healthcare.

Share

COinS